Ovid Therapeutics Inc.

NASDAQ
OVID
Stock
Yield per half year: -56.37%
Dividend yield: 0%
Sector: Healthcare
Current price
0.2893 $
Average price
0.2009 $ -30.56%
Price based on EPS
0.8685 $ +200.21%
Discount price Net Income
0.2009 $ -30.56%
0/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 0.8685 $
Current price = 0.2893 $ (difference = +200.21%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -4.38 $
Current price = 0.2893 $ (difference = -1 615.02%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -5.88 $
Current price = 0.2893 $ (difference = -2 133.5%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe